KFAA
MBII

Klaas Financial Asset Advisors’s Marrone Bio Innovations, Inc. MBII Stock Holding History

Klaas Financial Asset Advisors’s Portfolio MBII Stock Details MBII Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1,650
Closed -$3K – 89
2021
Q2 		$3K Hold
1,650
– – ﹤0.01% 85
2021
Q1 		$3K Hold
1,650
– – ﹤0.01% 81
2020
Q4 		$2K Buy
+1,650
New +$1.97K ﹤0.01% 77

Other funds holding MBII

Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UIC
Uniplan Investment Counsel Milwaukee, Wisconsin $974M AUM 21.37% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Klaas Financial Asset Advisors's MBII Position: Q3 2021 in Review

Klaas Financial Asset Advisors sold out of Marrone Bio Innovations, Inc. (MBII) in Q3 2021, closing a stake of 1,650 shares — an estimated $3K sold.

Klaas Financial Asset Advisors first reported a position in MBII in Q4 2020 and held it in 3 quarters. The position peaked at $3K in Q2 2021. 73 funds tracked by Wall St. Rank hold MBII as of Q3 2021.

  • Klaas Financial Asset Advisors reported no remaining Marrone Bio Innovations, Inc. position as of Q3 2021 after selling out during the quarter.
  • Klaas Financial Asset Advisors sold 1,650 Marrone Bio Innovations, Inc. shares in Q3 2021, an estimated $3K.
  • Klaas Financial Asset Advisors first reported a position in Marrone Bio Innovations, Inc. in Q4 2020 and held it in 3 quarters.
  • Klaas Financial Asset Advisors's Marrone Bio Innovations, Inc. position peaked at $3K in Q2 2021.
  • 73 funds tracked by Wall St. Rank held Marrone Bio Innovations, Inc. as of Q3 2021.

Based on Klaas Financial Asset Advisors's 13F filing for Q3 2021, filed 5 Nov 2021.